Skip to main content
Equibles
LMAT logo

LMAT · Lemaitre Vascular Inc · Metrics

Track LMAT — free

Use LMAT with AI

Add company filings, earnings and prices to ChatGPT or Claude, then ask questions in your own chat.

Choose your app for step-by-step connection instructions. Sign in with Equibles when asked; no code or API key is needed.

Claude ChatGPT

After connecting, ask your AI to use Equibles to research LMAT.

Other apps & server URL
https://mcp.equibles.com/mcp
Gemini CLI setup
or ask here

Free, nothing to set up — ALVIS runs on the same tools and cites every figure.

See what you can ask in ChatGPT or Claude

All connection guides →
$83.67 +0.27 (+0.32%) At close · Oct 21
S&P 600 member Russell 2000 member Rebalance outlook locked
Market Cap
$1.91B
Shares
22.87M
Volume · Oct 21 216.68K Avg daily vol (3M) 328.36K

LMAT metrics

93 of 122 screener metrics currently available.

Open in screener

Market overview

2 metrics
Share price
$83.67
Market cap
$1.91B

Price action

20 metrics
Price change (1W)
+1.3%
Price change (30D)
+3.3%
Price change (3M)
-15.3%
Price change (6M)
-25.8%
Price change (YTD)
+3.2%
Price change (1Y)
-6.8%
Trailing year
Price change (5Y)
+53.0%
52-week high
$117.39
52-week low
$78.80
Change from 52-week high
-28.7%
Change from 52-week low
+6.2%
Annualized volatility
44.8%
Annualized volatility (3M)
55.8%
Beta
0.4
RSI (14D)
56.6
Price vs SMA 50
+3.3%
Price vs SMA 200
-11.4%
Avg volume (3M)
328,358
Relative volume
0.7
Average dollar volume
$27.46M

Company

3 metrics
Sector
Healthcare
Industry
Medical Instruments & Supplies
Shares outstanding
22.87M

Valuation

12 metrics
P / E (TTM)
29.3
Trailing earnings · reciprocal yield 3.4%
PEG ratio
1.3
EV / revenue
—
EV / EBITDA
—
EV / EBIT
—
P / sales
7.3×
reciprocal yield 13.7%
P / book
4.6
reciprocal yield 22.0%
FCF yield
3.9%
TTM · current market cap
Buyback yield
0.1%
P / FCF
25.9
reciprocal yield 3.9%
P / operating cash flow
23.1
reciprocal yield 4.3%
Earnings yield
3.4%

Historical valuation

8 metrics
P / E historical average (3Y)
45.1×
reciprocal yield 2.2%
P / E historical average (5Y)
45.7×
reciprocal yield 2.2%
EV / revenue historical average (3Y)
—
EV / revenue historical average (5Y)
—
EV / EBIT historical average (3Y)
—
EV / EBIT historical average (5Y)
—
EV / EBITDA historical average (3Y)
—
EV / EBITDA historical average (5Y)
—

Dividends & buybacks

7 metrics
Dividend yield
1.1%
Trailing 12 months
Payout ratio
31.2%
Shareholder yield
1.2%
Dividend / share (TTM)
$0.95
Dividend growth YoY
+25.0%
Dividend growth streak
5+
Stored dividend history starts 2020
Last ex-dividend
2026-08-20

Earnings calendar

2 metrics
Next earnings
2026-11-04
Last earnings
2026-08-04

Profitability

9 metrics
Gross margin
72.9%
Operating margin
29.5%
Trailing 12 months
Net margin
25.0%
Gross profit (TTM)
$191.31M
Operating profit (TTM)
$77.32M
Net income (TTM)
$65.67M
Trailing 12 months
Diluted EPS (TTM)
$2.86
FCF margin
28.1%
Effective tax rate
22.5%

Per share

11 metrics
Revenue per diluted share (TTM)
—
Gross profit per diluted share (TTM)
—
Operating profit per diluted share (TTM)
—
EBITDA per diluted share (TTM)
—
Net income per diluted share (TTM)
—
Operating cash flow per diluted share (TTM)
—
Free cash flow per diluted share (TTM)
—
Capital expenditures per diluted share (TTM)
—
R&D per diluted share (TTM)
—
Stock compensation per diluted share (TTM)
—
Book value per share
$17.28

Growth

11 metrics
Revenue growth YoY
+9.6%
Year over year
Net income growth YoY
+23.7%
Revenue (TTM)
$262.43M
Trailing 12 months
EPS growth YoY
+23.3%
Shares change YoY
+7.2%
Year over year · more shares
Revenue CAGR (3Y)
+15.6%
Revenue CAGR (5Y)
+14.0%
EPS CAGR (3Y)
+39.4%
EPS CAGR (5Y)
+19.4%
FCF CAGR (3Y)
+49.8%
FCF CAGR (5Y)
+18.5%

Quality

14 metrics
Return on equity
15.6%
Return on assets
10.3%
Debt / equity
—
Current ratio
16.3
EBITDA (TTM)
$87.82M
Free cash flow (TTM)
$73.83M
Quick ratio
—
Interest coverage
14.9
Net debt / EBITDA
-0.3
Return on invested capital
—
Trailing 12 months
Net cash
$26.62M
Latest balance sheet
Cash & equivalents
$26.62M
Total assets
$640.55M
Total debt
—

Cash flow & spend

7 metrics
Operating cash flow (TTM)
$82.98M
Capital expenditures (TTM)
$9.15M
R&D (TTM)
$15.41M
SG&A (TTM)
—
Stock compensation (TTM)
$7.86M
R&D / revenue
5.9%
Stock compensation / revenue
3.0%

Ownership (13F)

9 metrics
13F filers
328
13F filer change QoQ
-13
Institutional ownership
100.0%
Conviction holders (share of 13F filers)
0.6%
Crowding (high-turnover and private-fund holders)
—
Private-fund adviser ownership
—
Active holders' share change QoQ
+2.8%
Holder tenure
17.6
Price vs estimated holder cost
+12.3%

Ownership (registered funds)

1 metrics
Index-fund ownership
28.4%

Short interest

3 metrics
Short interest
7.6%
Latest settlement · 6.9 days to cover
Days to cover
6.9d
Short-squeeze score
66 / 100

Insider activity

2 metrics
Net insider buying (90D)
—
Insider-sentiment score
—

Risk flags

1 metrics
Going concern
—
Key facts CIK 1158895 CUSIP 525558201 13F (30d) 38 filings 38 filers Visit website Investor relations